Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2026-01-11 @ 1:17 AM
Study NCT ID:
NCT04164758
Status:
TERMINATED
Last Update Posted:
2021-10-14
First Post:
2019-11-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine
Sponsor:
ACADIA Pharmaceuticals Inc.
Organization: